April 10, 2024

Intravascular Microaxial Left Ventricular Assist Device Manufacturer Payments to Cardiologists and Use of Devices

Key Points

Key points are not available for this paper at this time.

Abstract

This study examines whether payments from a left ventricular assist device manufacturer to cardiologists performing percutaneous coronary intervention were associated with any use of the devices.

اسأل الذكاء الاصطناعي

Bookmark

Cite This Study

Dhruva et al. (Wed,) studied this question.

synapsesocial.com/papers/68e6f97db6db643587674525 https://doi.org/https://doi.org/10.1001/jama.2024.4682

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock2019 · 504 citations
2Clinical Outcomes and Cost Associated With an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump in Patients Presenting With Acute Myocardial Infarction Complicated by Cardiogenic Shock2022 · 99 citations
3Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock2020 · 373 citations
4Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study2016 · 146 citations
5Association of Device Industry Payments, Physician Supply, and Regional Utilization of Orthopedic and Cardiac Procedures2023 · 8 citations

اسأل الذكاء الاصطناعي

Bookmark